2016
GENREMonograph
AUTHORSKyu-Won Kim , Jae Kyung Roh , Hee-Jun Wee , Chan Kim
PUBLISHERSpringer Nature
ABSTRACTThis book describes the history of cancer drugs development to provide insight into the successes and the shortcomings of this enterprise. Most cancer drug treatments target the cancer cell as the core component and as such are very effective in inhibiting their proliferation. However, these cancer drugs are generally ineffective against metastasis, which are tightly linked to the whole body as a system. This book illustrates the problems in cancer drug design and suggests a more systemic view of cancer with a more adapted research approach. The reader will discover a comprehensive and multifaceted overview of the history of the development of anticancer drugs, which has been deeply influenced by the ‘cell concept’ of cancer. Future directions for the development of new anticancer drugs will also be presented. This book has been separated into three sections, providing an overview of: - The scientific progress in the biological sciences over the last 60 years and the influence this progress has had in cancer research. Summaries and charts of important discoveries complete this overview - The process of anticancer drug development with a focus on the characteristic drug groups of each era, illustrated by comprehensive timelines and conceptual cartoons - The limitations of the current cancer drug development pipelines and the new directions for cancer drug discovery, considering a more systemic view of cancer This book is a useful reference for scientists and clinicians working in the biomedical field and for oncologists aiming to explore the landscape of human endeavor in the fight against cancer. More... »
http://scigraph.springernature.com/pub.10.1007/978-94-024-0844-7
DOIhttp://dx.doi.org/10.1007/978-94-024-0844-7
ISBN978-94-024-0842-3 | 978-94-024-0844-7
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1027629587
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "College of Pharmacy, Seoul National University, Seoul, Korea (Republic of)",
"id": "http://www.grid.ac/institutes/grid.31501.36",
"name": [
"College of Pharmacy, Seoul National University, Seoul, Korea (Republic of)"
],
"type": "Organization"
},
"familyName": "Kim",
"givenName": "Kyu-Won",
"id": "sg:person.01065575374.60",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065575374.60"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (Republic of)",
"id": "http://www.grid.ac/institutes/grid.15444.30",
"name": [
"Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (Republic of)"
],
"type": "Organization"
},
"familyName": "Roh",
"givenName": "Jae Kyung",
"id": "sg:person.0767622633.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "College of Pharmacy, Seoul National University, Seoul, Korea (Republic of)",
"id": "http://www.grid.ac/institutes/grid.31501.36",
"name": [
"College of Pharmacy, Seoul National University, Seoul, Korea (Republic of)"
],
"type": "Organization"
},
"familyName": "Wee",
"givenName": "Hee-Jun",
"id": "sg:person.015431667017.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015431667017.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, Korea (Republic of)",
"id": "http://www.grid.ac/institutes/grid.452398.1",
"name": [
"Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, Korea (Republic of)"
],
"type": "Organization"
},
"familyName": "Kim",
"givenName": "Chan",
"id": "sg:person.01274627441.40",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627441.40"
],
"type": "Person"
}
],
"datePublished": "2016",
"datePublishedReg": "2016-01-01",
"description": "This book describes the history of cancer drugs development to provide insight into the successes and the shortcomings of this enterprise. Most cancer drug treatments target the cancer cell as the core component and as such are very effective in inhibiting their proliferation. However, these cancer drugs are generally ineffective against metastasis, which are tightly linked to the whole body as a system. This book illustrates the problems in cancer drug design and suggests a more systemic view of cancer with a more adapted research approach. The reader will discover a comprehensive and multifaceted overview of the history of the development of anticancer drugs, which has been deeply influenced by the \u2018cell concept\u2019 of cancer. Future directions for the development of new anticancer drugs will also be presented. This book has been separated into three sections, providing an overview of: - The scientific progress in the biological sciences over the last 60 years and the influence this progress has had in cancer research. Summaries and charts of important discoveries complete this overview - The process of anticancer drug development with a focus on the characteristic drug groups of each era, illustrated by comprehensive timelines and conceptual cartoons - The limitations of the current cancer drug development pipelines and the new directions for cancer drug discovery, considering a more systemic view of cancer This book is a useful reference for scientists and clinicians working in the biomedical field and for oncologists aiming to explore the landscape of human endeavor in the fight against cancer.",
"genre": "monograph",
"id": "sg:pub.10.1007/978-94-024-0844-7",
"inLanguage": "en",
"isAccessibleForFree": false,
"isbn": [
"978-94-024-0842-3",
"978-94-024-0844-7"
],
"keywords": [
"cancer drug discovery",
"drug discovery",
"anticancer drugs",
"new anticancer drugs",
"cancer drug design",
"drug design",
"anticancer drug development",
"biomedical field",
"drug development",
"drug development pipeline",
"cancer drugs",
"cancer drug development",
"development pipeline",
"biological sciences",
"discovery",
"cancer drug treatment",
"drugs",
"cell concept",
"cancer cells",
"important discoveries",
"overview",
"progress",
"comprehensive timeline",
"new directions",
"future directions",
"process",
"useful reference",
"development",
"insights",
"science",
"influence",
"cancer research",
"group",
"cells",
"components",
"system",
"design",
"scientists",
"field",
"core component",
"approach",
"multifaceted overview",
"direction",
"scientific progress",
"limitations",
"shortcomings",
"treatment",
"proliferation",
"systemic view",
"view",
"cancer",
"reference",
"landscape",
"endeavor",
"drug treatment",
"whole body",
"readers",
"concept",
"sections",
"research",
"summary",
"focus",
"pipeline",
"history",
"success",
"metastasis",
"body",
"human endeavor",
"fight",
"book",
"problem",
"years",
"drug groups",
"timeline",
"research approach",
"charts",
"era",
"clinicians",
"oncologists",
"cartoons",
"enterprises"
],
"name": "Cancer Drug Discovery, Science and History",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1027629587"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-94-024-0844-7"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-94-024-0844-7",
"https://app.dimensions.ai/details/publication/pub.1027629587"
],
"sdDataset": "books",
"sdDatePublished": "2022-05-20T07:40",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/book/book_19.jsonl",
"type": "Book",
"url": "https://doi.org/10.1007/978-94-024-0844-7"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-024-0844-7'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-024-0844-7'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-024-0844-7'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-024-0844-7'
This table displays all metadata directly associated to this object as RDF triples.
158 TRIPLES
21 PREDICATES
106 URIs
99 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-94-024-0844-7 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1112 |
3 | ″ | schema:author | Nb3af3530be15474a9355d5de6b977547 |
4 | ″ | schema:datePublished | 2016 |
5 | ″ | schema:datePublishedReg | 2016-01-01 |
6 | ″ | schema:description | This book describes the history of cancer drugs development to provide insight into the successes and the shortcomings of this enterprise. Most cancer drug treatments target the cancer cell as the core component and as such are very effective in inhibiting their proliferation. However, these cancer drugs are generally ineffective against metastasis, which are tightly linked to the whole body as a system. This book illustrates the problems in cancer drug design and suggests a more systemic view of cancer with a more adapted research approach. The reader will discover a comprehensive and multifaceted overview of the history of the development of anticancer drugs, which has been deeply influenced by the ‘cell concept’ of cancer. Future directions for the development of new anticancer drugs will also be presented. This book has been separated into three sections, providing an overview of: - The scientific progress in the biological sciences over the last 60 years and the influence this progress has had in cancer research. Summaries and charts of important discoveries complete this overview - The process of anticancer drug development with a focus on the characteristic drug groups of each era, illustrated by comprehensive timelines and conceptual cartoons - The limitations of the current cancer drug development pipelines and the new directions for cancer drug discovery, considering a more systemic view of cancer This book is a useful reference for scientists and clinicians working in the biomedical field and for oncologists aiming to explore the landscape of human endeavor in the fight against cancer. |
7 | ″ | schema:genre | monograph |
8 | ″ | schema:inLanguage | en |
9 | ″ | schema:isAccessibleForFree | false |
10 | ″ | schema:isbn | 978-94-024-0842-3 |
11 | ″ | ″ | 978-94-024-0844-7 |
12 | ″ | schema:keywords | anticancer drug development |
13 | ″ | ″ | anticancer drugs |
14 | ″ | ″ | approach |
15 | ″ | ″ | biological sciences |
16 | ″ | ″ | biomedical field |
17 | ″ | ″ | body |
18 | ″ | ″ | book |
19 | ″ | ″ | cancer |
20 | ″ | ″ | cancer cells |
21 | ″ | ″ | cancer drug design |
22 | ″ | ″ | cancer drug development |
23 | ″ | ″ | cancer drug discovery |
24 | ″ | ″ | cancer drug treatment |
25 | ″ | ″ | cancer drugs |
26 | ″ | ″ | cancer research |
27 | ″ | ″ | cartoons |
28 | ″ | ″ | cell concept |
29 | ″ | ″ | cells |
30 | ″ | ″ | charts |
31 | ″ | ″ | clinicians |
32 | ″ | ″ | components |
33 | ″ | ″ | comprehensive timeline |
34 | ″ | ″ | concept |
35 | ″ | ″ | core component |
36 | ″ | ″ | design |
37 | ″ | ″ | development |
38 | ″ | ″ | development pipeline |
39 | ″ | ″ | direction |
40 | ″ | ″ | discovery |
41 | ″ | ″ | drug design |
42 | ″ | ″ | drug development |
43 | ″ | ″ | drug development pipeline |
44 | ″ | ″ | drug discovery |
45 | ″ | ″ | drug groups |
46 | ″ | ″ | drug treatment |
47 | ″ | ″ | drugs |
48 | ″ | ″ | endeavor |
49 | ″ | ″ | enterprises |
50 | ″ | ″ | era |
51 | ″ | ″ | field |
52 | ″ | ″ | fight |
53 | ″ | ″ | focus |
54 | ″ | ″ | future directions |
55 | ″ | ″ | group |
56 | ″ | ″ | history |
57 | ″ | ″ | human endeavor |
58 | ″ | ″ | important discoveries |
59 | ″ | ″ | influence |
60 | ″ | ″ | insights |
61 | ″ | ″ | landscape |
62 | ″ | ″ | limitations |
63 | ″ | ″ | metastasis |
64 | ″ | ″ | multifaceted overview |
65 | ″ | ″ | new anticancer drugs |
66 | ″ | ″ | new directions |
67 | ″ | ″ | oncologists |
68 | ″ | ″ | overview |
69 | ″ | ″ | pipeline |
70 | ″ | ″ | problem |
71 | ″ | ″ | process |
72 | ″ | ″ | progress |
73 | ″ | ″ | proliferation |
74 | ″ | ″ | readers |
75 | ″ | ″ | reference |
76 | ″ | ″ | research |
77 | ″ | ″ | research approach |
78 | ″ | ″ | science |
79 | ″ | ″ | scientific progress |
80 | ″ | ″ | scientists |
81 | ″ | ″ | sections |
82 | ″ | ″ | shortcomings |
83 | ″ | ″ | success |
84 | ″ | ″ | summary |
85 | ″ | ″ | system |
86 | ″ | ″ | systemic view |
87 | ″ | ″ | timeline |
88 | ″ | ″ | treatment |
89 | ″ | ″ | useful reference |
90 | ″ | ″ | view |
91 | ″ | ″ | whole body |
92 | ″ | ″ | years |
93 | ″ | schema:name | Cancer Drug Discovery, Science and History |
94 | ″ | schema:productId | N0440c766ec9a4f98bfea2b5dbf3eda76 |
95 | ″ | ″ | N138bad9956754e369c16185881c7d418 |
96 | ″ | schema:publisher | N312933bc002a4d4a84dfb85723ef023a |
97 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1027629587 |
98 | ″ | ″ | https://doi.org/10.1007/978-94-024-0844-7 |
99 | ″ | schema:sdDatePublished | 2022-05-20T07:40 |
100 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
101 | ″ | schema:sdPublisher | N0e527c545c48471ab520ef5f0dc60216 |
102 | ″ | schema:url | https://doi.org/10.1007/978-94-024-0844-7 |
103 | ″ | sgo:license | sg:explorer/license/ |
104 | ″ | sgo:sdDataset | books |
105 | ″ | rdf:type | schema:Book |
106 | N0440c766ec9a4f98bfea2b5dbf3eda76 | schema:name | doi |
107 | ″ | schema:value | 10.1007/978-94-024-0844-7 |
108 | ″ | rdf:type | schema:PropertyValue |
109 | N0e527c545c48471ab520ef5f0dc60216 | schema:name | Springer Nature - SN SciGraph project |
110 | ″ | rdf:type | schema:Organization |
111 | N138bad9956754e369c16185881c7d418 | schema:name | dimensions_id |
112 | ″ | schema:value | pub.1027629587 |
113 | ″ | rdf:type | schema:PropertyValue |
114 | N312933bc002a4d4a84dfb85723ef023a | schema:name | Springer Nature |
115 | ″ | rdf:type | schema:Organisation |
116 | N71a76e6e8e304e55a3f5a03ec138160c | rdf:first | sg:person.0767622633.82 |
117 | ″ | rdf:rest | Na6e0121a61c84d2ab7e53894eb4d46a2 |
118 | N92da8f6bece34cceb2ecdd5e444c1019 | rdf:first | sg:person.01274627441.40 |
119 | ″ | rdf:rest | rdf:nil |
120 | Na6e0121a61c84d2ab7e53894eb4d46a2 | rdf:first | sg:person.015431667017.24 |
121 | ″ | rdf:rest | N92da8f6bece34cceb2ecdd5e444c1019 |
122 | Nb3af3530be15474a9355d5de6b977547 | rdf:first | sg:person.01065575374.60 |
123 | ″ | rdf:rest | N71a76e6e8e304e55a3f5a03ec138160c |
124 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
125 | ″ | schema:name | Medical and Health Sciences |
126 | ″ | rdf:type | schema:DefinedTerm |
127 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
128 | ″ | schema:name | Oncology and Carcinogenesis |
129 | ″ | rdf:type | schema:DefinedTerm |
130 | sg:person.01065575374.60 | schema:affiliation | grid-institutes:grid.31501.36 |
131 | ″ | schema:familyName | Kim |
132 | ″ | schema:givenName | Kyu-Won |
133 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065575374.60 |
134 | ″ | rdf:type | schema:Person |
135 | sg:person.01274627441.40 | schema:affiliation | grid-institutes:grid.452398.1 |
136 | ″ | schema:familyName | Kim |
137 | ″ | schema:givenName | Chan |
138 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274627441.40 |
139 | ″ | rdf:type | schema:Person |
140 | sg:person.015431667017.24 | schema:affiliation | grid-institutes:grid.31501.36 |
141 | ″ | schema:familyName | Wee |
142 | ″ | schema:givenName | Hee-Jun |
143 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015431667017.24 |
144 | ″ | rdf:type | schema:Person |
145 | sg:person.0767622633.82 | schema:affiliation | grid-institutes:grid.15444.30 |
146 | ″ | schema:familyName | Roh |
147 | ″ | schema:givenName | Jae Kyung |
148 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82 |
149 | ″ | rdf:type | schema:Person |
150 | grid-institutes:grid.15444.30 | schema:alternateName | Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (Republic of) |
151 | ″ | schema:name | Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (Republic of) |
152 | ″ | rdf:type | schema:Organization |
153 | grid-institutes:grid.31501.36 | schema:alternateName | College of Pharmacy, Seoul National University, Seoul, Korea (Republic of) |
154 | ″ | schema:name | College of Pharmacy, Seoul National University, Seoul, Korea (Republic of) |
155 | ″ | rdf:type | schema:Organization |
156 | grid-institutes:grid.452398.1 | schema:alternateName | Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, Korea (Republic of) |
157 | ″ | schema:name | Department of Internal Medicine, CHA Bundang Medical Center, Seongnam, Korea (Republic of) |
158 | ″ | rdf:type | schema:Organization |